Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: heidi s who wrote (29557)	3/25/1999 7:13:00 PM
From: kha vu	Respond to of 120523

BEAM...VISX... Do you recall that when VISX submitted to FDA for clinical clearance ...and this proposals ended at BEAM headquarter ? Do you recall that both VISX and BEAM has to dissolve the organization that both VISX and BEAM setup to further the research in vision, because the fed thought that they violated the anti trust law. VISX and BEAM collected the royalties and splitted the shares thru a formula based on the market captures Do you recall that both were at once time exported their machines/equipments to europe - because in this part of the world they can have the procedures performed while waiting for FDA approvals... then due to the demand in USA, they re-imported and refurbished them to USA.... These are a few infos I just got out of the vertical files at an investment bank... If you look at the stock price charts back to Jan 1996: quote.yahoo.com Beam was a leading company in the field then it lost too much on the side business: lens ... and the picture reverses... in the last three months with VISX leading the field. This is a momentum stock for a intermediate hold because VISX has the institutions committed to it.